Prognostic value of preoperative neutrophil-to-lymphocyte ratio in histological variants of non-muscle-invasive bladder cancer

Investig Clin Urol. 2021 Nov;62(6):641-649. doi: 10.4111/icu.20210278.

Abstract

Purpose: Many studies identified that the preoperative neutrophil-to-lymphocyte ratio (PNLR) was associated with patient prognosis in non-muscle-invasive bladder cancer (NMIBC). We hypothesized that PNLR could be prognostic in patients with histological variants of NMIBC (VH-NMIBC).

Materials and methods: This retrospective study included patients with VH-NMIBC admitted at our center between January 2009 and May 2019. The best cut-off value of NLR was measured by the receiver operating characteristic curve and Youden index. The Kaplan-Meier method and Cox proportional hazard regression models were employed to evaluate the association between PNLR and disease prognosis, including recurrence-free survival (RFS), progression-free survival (PFS), cancer-specific survival (CSS), and overall survival (OS).

Results: A total of 243 patients with VH-NMIBC were enrolled in our study. According to the Kaplan-Meier method results, patients with PNLR ≥2.2 were associated with poor RFS (p<0.001), PFS (p<0.001), CSS (p<0.001), and OS (p<0.001). Multivariable analyses indicated that PNLR ≥ 2.2 was an independent prognostic factor of RFS (hazard ratio [HR], 2.11; 95% confidence interval [CI, 1.57-1.83; p<0.001), PFS (HR, 2.34; 95% CI, 1.70-3.21; p<0.001), CCS (HR, 2.87; 95% CI, 1.96-4.18; p< 0.001), and OS (HR, 2.83; 95% CI, 1.96-4.07; p<0.001).

Conclusions: This study identified that PNLR ≥2.2 was usually associated with a poor prognosis for patients with VH-NMIBC.

Keywords: Bladder cancer; Histology; Lymphocyte; Neutrophil; Prognosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cystectomy* / adverse effects
  • Cystectomy* / methods
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Lymphocyte Count* / methods
  • Lymphocyte Count* / statistics & numerical data
  • Lymphocytes / pathology*
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Neutrophils / pathology*
  • Predictive Value of Tests
  • Preoperative Care / methods
  • Prognosis
  • Proportional Hazards Models
  • Urinary Bladder Neoplasms* / diagnosis
  • Urinary Bladder Neoplasms* / mortality
  • Urinary Bladder Neoplasms* / pathology
  • Urinary Bladder Neoplasms* / surgery